Patterns of Primary Care and Survival in 336 Consecutive Unselected Norwegian Patients With Bladder Cancer

References

• Barnes RW, Dick AL, Hadley HL et al. Survival following transurethral resection of bladder carcinoma. Cancer Res 1977; 37; 2895–2897.
   Google Scholar
• Beisland HO, Sander S. Neodymium-YAG laser irradiation of stage T2 muscle-invasive bladder cancer. Long-term results. Br J Urol 1990; 65; 24–26.
   Google Scholar
• Cifuentes Delatte L, Garcia de la Pena E, Vela Navarrete R. Survival rates of patients with bladder tumours. An experience of 1 744 cases (1950–1978). Br J Urol 1982; 54: 267–274.
   Google Scholar
• Eidsmyr F, Andersson L, Esposti PL, Littbrand B, Nilsson B. Irradiation therapy with multiple small fractions per day in urinary bladder cancer. Radiother Oncol 1985; 4: 197–203.
   Google Scholar
• Fosså SD, Hosbach G. Ineffectiveness of short-term moderate dose (30 Gy) pelvic palliation radiotherapy of advanced bladder carcinoma. Acta Oncol 1991; 30: 735–738.
   Google Scholar
• Fosså SD, Mead GH, Harland SJ, Kaye B, Raghaven D, Parmar MKB, Uscinska BM. Combination therapy with cisplat in methotrexate and vinblastine in locally advanced transitional cell bladder carcinoma: Response rate and pitfalls. Br J Urol 1991; 67: 54–60.
   Google Scholar
• Fosså SD, Ous S, Berner Aa. The clinical significance of the “palpable mass” in patients with muscle-infiltrating bladder cancer undergoing cystectomy after pre-operative radiotherapy. Br J Urol 1991; 67: 34–60.
   Google Scholar
• Fosså SD, Ous S, Knudsen OS. Radical irradiation of T2 and T3 bladder carcinoma. Acta Radiol Oncol 1985; 24: 497–501.
   Google Scholar
• Husband JES, Olliff JFC, Williams MP, Heron CW, Cherrvman GR. Bladder staging with CT and MR imaging. Radiology 1989; 173: 435–440.
   Google Scholar
• Jacobscn A-B, Nesland JM, Fosså SD, Pettersen EO. Human chorionic gonadotropin, neuron specific enolase and DNA flow cytometry in patients with high grade bladder carcinoma. J Urol 1990; 143: 706–709.
   Google Scholar
• Jacobscn A-B. Lunde S, Ous S, Melvik JE, Pettersen EO, Kaalhus O, Fosså SD. Multivariate analysis in 121 patients with T2/T3 bladder carcinomas treated with definitive radiotherapy with emphasis on How cytometric DNA ploidy values. A study on paraffin-embedded tumour tissue. Int J Radiat Oncol Biol Phys 1989; 17: 923–929.
   Google Scholar
• Lipponcn PK, Eskelinen MJ, Collan Y, Pesonen E, Ventilä T, Sotarauta M, Nordling S. DNA ploidy and S phase fraction in human bladder cancer. Urol Int 1990; 45: 4–9.
   Google Scholar
• MRC/EORTC. A randomised trial of primary chemotherapy in locally advanced bladder cancer. BA 06/30894, 1989.
   Google Scholar
• Malmström P-U, Busch C, Norlén BJ, Andersson B. Expression of ABH blood group isoantigen as a prognostic factor in transitional cell bladder carcinoma. Scand J Urol Nephrol 1988; 22: 265–270.
   Google Scholar
• Malmström P-U, Busch C, Norlén BJ. Recurrence progression and survival in bladder cancer. A retrospective analysis in 232 patients with ≥ 5-year follow-up. Scand J Urol Nephrol 1987; 21: 185–195.
   Google Scholar
• Marcial VA, Amato DA, Brady LW, Johnson RJ, Goodman R, Martz KL, Hanley JA. Split-course radiotherapy of carcinoma of the urinary bladder stages C and D,. A radiation therapy onclology group study. Am J Clin Oncol 1985; 8: 185–199.
   Google Scholar
• Neal DE, Sharpies L, Smith K, Fennelly J, Hall RR, Harris AL. The epidermal growth factor receptor and the prognosis of bladder cancer. Cancer 1990; 65: 1619–1625.
   Google Scholar
• Ooms ECM, Anderson WAD, Alons CL. Boon ME, Veldhuizen RW. Analysis of the performance of pathologists in the grading of bladder tumours. Hum Pathol 1983; 14: 140–143.
   Google Scholar
• Prout GR, Griffin PP, Shipley WU. Bladder carcinoma as a systemic disease. Cancer 1979; 43: 2532–2539.
   Google Scholar
• Quilty PM, Kerr GR, Duncan W. Prognostic indices for bladder cancer: An analysis of patients with transitional cell carcinoma of the bladder primarily treated by radical megavoltage X-ray therapy. Radiother Oncol 1986; 7: 311–321.
   Google Scholar
• Richards B, Bastable JRG, Freedman L, Glashan RW, Harris G, Newling DWW, Robinson MRG, Smith PH and the Yorkshire Urology Cancer Research Group. Adjuvant chemotherapy with doxyrubicin (Adriamycin) and 5-fluorouracil in T3, NX MO bladder cancer treated with radiotherapy. Br J Urol 1983; 55: 386–391.
   Google Scholar
• Sager EM, Fosså SD, Kaalhus O, Talle K. Contrast-enhanced CT in carcinoma of the urinary bladder. The use of different injection methods. Acta Radiol (Diagn) 1987; 28: 67–70.
   Google Scholar
• Shearer RJ, Chilvers CED, Bloom HJG, Bliss JM, Horwich A, Babiker A for the Co-operative Urological Cancer Group. Adjuvant chemotherapy in T3 carcinoma of the bladder. Br J Urol 1988; 62: 558–564.
   Google Scholar
• Scher H, Herr H, Sternberg C, Fair W, Bosl G, Morse M, Sogani P, Watson R, Dershaw D, Reuter V, Curley T, Darracott Vaughan E, Whitmore W, Yagoda A. Nco-adjuvant chemotherapy for invasive bladder cancer. Experience with the M-VAC regimen. Br J Urol 1989; 64: 250–256.
   Google Scholar
• Shipley WU, Rose MA, Perrone TL, Mannix CM, Heney NM, Prout GR. Full-dose irradiation for patients with invasive bladder carcinoma: Clinical and histological factors prognostic of improved survival. J Urol 1985; 134: 679–683.
   Google Scholar
• Skinner DG, Lieskovsky G. Contemporary cystectomy with pelvic node dissection compared to preoperative radiation therapy plus cystectomy in management of invasive bladder cancer. J Urol 1984; 131: 1069–1072.
   Google Scholar
• Sternberg C, Yagoda A, Scher HI, Watson RC, Herr HW, Morse MJ, Sogani RC, Darracott Vaughan E Jr, Bander N, Wieselberg LR, Geller N, Hollander PS. Lipperman R, Fair WR, Whit-more WF Jr. M-VAC (Methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium. J Urol 1988; 139: 461–469.
   Google Scholar
• UICC. Harmer MH, ed. TNM classification of malignant tumours. 3rd ed. Geneva: 1978: 113–117.
   Google Scholar
• van der Werf-Messing B, Hop WCJ. Carcinoma of the urinary bladder (category T1NxM0) treated either by radium implant or by transurethral resection only. Int J Radiat Oncol Biol Phys 1981; 7: 299–303.
   Google Scholar
• Whitmore WF, Batata M. Status of integrated irradiation and cystectomy for bladder cancer. Urol Clin North Am 1984; 4: 681–691.
   Google Scholar
• Younes M, Sussman J, True LD. The usefulness of the level of the muscularis mucosae in the staging of invasive transitional cell carcinoma of the urinary bladder. Cancer 1990; 66: 543–548.
   Google Scholar
• Zincke H, Patterson DE, Utz DC, Benson RC. Pelvic lymphadenectomy and radical cystectomy for transitional cell carcinoma of the bladder with pelvic nodal disease. Br J Urol 1985; 57: 156–159.
   Google Scholar